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ABSTRACT

Cognitive-behavioral therapy (CBT) with exposure is an effective treatment for
anxiety disorders but involves acute discomfort, rendering treatment engagement a
challenge. Willingness to engage in exposure is of interest, because a child has to
willingly approach a feared stimulus. This preliminary study investigated child
engagement during exposures in CBT for anxiety disorders, with the development,
validation, and field testing of a measure of self-efficacy over three time points. The
measure, Self-Efficacy During Exposure-Child (SEE-C), is a 9-item, self-report measure
of self-efficacy during exposure for youth 8-17 years old. A sample of eight reviewers at
least 2-years post licensure (M = 14.06; SD = 4.71) with expertise in CBT for childhood
anxiety provided feedback on the SEE-C’s face and content validity. Field testing
included a sample of 24 child-parent dyads recruited from an anxiety clinic in the
Northeast U.S. Child-parent dyads were asked to complete measures of child selfefficacy; child anxiety symptoms; and child school, social, and family functioning.
Children were also asked to complete a measure of motivation. Analyses revealed the
SEE-C to demonstrate significant increases in child self-efficacy, reductions in child
anxiety symptoms, and increases in social and family functioning over treatment. Internal
consistency of the SEE-C was acceptable to excellent, and exploratory principle
component analysis suggested a three-factor solution, with loadings ranging from 0.5 to
0.9. The SEE-C adds to the literature as the first measure of child self-efficacy designed
for use during exposure in CBT for anxiety. Findings provide insight into those factors
that contribute to a child’s engagement during exposure. Reported effect sizes are
promising and warrant greater investigation of the SEE-C’s utility.
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CHAPTER 1

INTRODUCTION
Anxiety disorders among children and adolescents require effective
interventions due to their often unrelenting symptomatology causing distress and
impairment in family, academic, and social functioning, as well as reduced quality of
life (Costello, Egger, & Angold, 2005; Ezpeleta, Keeler, Erkanli, Costello, & Angold,
2001; Piacentini, Bergman, Keller, & McCracken, 2003; Valderhaug & Ivarsson,
2005). Cognitive-behavioral therapy (CBT) for anxiety disorders among children and
adolescents, particularly those incorporating exposure practice, have been empirically
supported and denoted efficacious by a considerable amount of clinical outcome
research (e.g., Compton, Peris, Almirall, Birmaher, Sherrill, Kendall, et al., 2014;
Higa-McMillan, Francis, Rith-Najarian, & Chorpita, 2015; Kendall, FlannerySchroeder, Panichelli-Mindel, Southam-Gerow, Henin, & Warman, 1997). CBT with
exposure is a variant of CBT that is purported to work via exposure, where exposure is
defined as “a controlled therapeutic task in which a person confronts an anxietyprovoking stimulus or situation” (Marks, 1973). As such, anxiety and fear reduction
occurs through contact with the feared stimulus.
While CBT with exposure is identified as an effective treatment for childhood
anxiety disorders, it involves much acute discomfort, thus rendering treatment
engagement during exposure with children and adolescents a challenge. A focus on
exposure practice during treatment is necessary, however, as it is considered a primary
mechanism and an active “ingredient” in anxiety reduction (Peris et al., 2015). As a
result, questions about the exposure process have arisen. For example, how does a
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child in CBT for anxiety begin to engage in and utilize exposure to “fight” their
anxiety? Also, when does the child begin to experience a reduction in anxiety during
exposure? Further, does a reduction of a child’s anxiety during exposure within
session lead to future reductions of anxiety during exposure across session within the
CBT with exposure treatment trajectory?
Social psychology, sports psychology, and behavioral economics each study
the performance-enhancing concept of positive psychological momentum (PPM).
Rooted in attribution theory (the study of the processes by which individuals explain
the causes of behavior and events), PPM is defined as the “perception, attitude, belief,
or state-of-mind an individual experiences, in which their initial success leads to more
successes” (Iso-Ahola & Blanchard, 1986). Positive psychological momentum theory
posits that perceived positive momentum leads to increased confidence; thus, in turn,
leading to more active and better performance (Rosenqvist & Nordström Skans, 2015).
In line with this phenomenon, Compte and Postlewaite (2004) suggest that a causal
link may exist from past successes to future performance through “confidence,” where
confidence is defined as one's belief in one's ability to succeed in specific situations or
accomplish a task (Iso-Ahola & Dotson, 2014). However, given the definition of
confidence, it seems that before an individual can perceive confidence, they have to
first perceive self-efficacy. Self-efficacy is the belief one has about their ability to
perform a certain task (Bandura, 1997 & 1988); thus, one will have confidence when
self-efficacy is utilized to competently complete a task multiple times. The concept of
PPM may also be used to explain enhanced performance within the context of
enhancing a child/adolescent’s motivation (the process that initiates, guides, and
maintains goal-oriented behaviors). The theory of PPM, if shown to have a causal
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relationship with self-efficacy and motivation by which “success leads to success,”
could be used to enhance performance not only within sports or entrepreneurial
endeavors, but also within the context of enhancing youth motivation and self-efficacy
to complete exposure tasks in CBT treatments.
Child Engagement During Exposure in CBT for Childhood Anxiety Disorders
A child’s willingness to engage in and adhere to exposure practice during CBT
is of great interest, because exposures cannot be “done” to a child. Rather, a child has
to willingly participate in a task that focuses on a feared stimulus in order for the fear
to reduce. Engagement (the act of occupying the attention or efforts of a person, and in
this case, a child) in exposure is made up of multiple factors. However, to date, there
is a significant gap in the literature, as no investigations have been found related to
child factors that contribute to engagement during the utilization of exposure. Thus,
the study of these factors is needed.
While no studies have examined child engagement during exposure sessions,
some research has investigated child engagement more generally during CBT
treatment. For example, Morgan and colleagues (2013) explored the relationship
between poor treatment adherence and attenuated treatment response in pediatric OCD
and found that a child’s willingness to engage in exposure mediated overall treatment
outcomes. Morgan and colleagues’ (2013) study supports the need for additional
research regarding treatment engagement in exposure, yet, does not examine the childspecific factors that may be identified as necessary for engagement during exposure.
Relatedly, King, Currie, and Petersen (2014) examined factors of child
engagement in mental health treatment and assert that it involves a motivational
commitment to the intervention process. They suggested that this process includes
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behavioral involvement such as child in-session participation, therapist and child
collaboration, and the child’s self-efficacy to continue in the identified intervention.
Thus, a child’s in-session motivation to experience and feel distress in the face of a
feared stimulus along with their perceived self-efficacy may be two important factors
in engagement during exposure.
While there are many factors that make up child and adolescent treatment
engagement during exposure in CBT for childhood anxiety, including caregiver
(hereinafter referred to as “parent”) factors and clinician factors, motivation and
perceived self-efficacy are two child factors purported to contribute to engagement
within the theory of positive psychological momentum. Yet, there is a real need for the
development of assessment tools to measure these constructs. The present study will
focus on the latter (i.e., self-efficacy), as a review of the literature demonstrates the
absence of such a measure.
Self-efficacy: A Factor to be Explored
Perceived self-efficacy has been studied within the context of fear reduction
and phobias (Bandura, 1977, 1978, 1982, 1998) and is posited to improve one’s
expectation of achievement. Though perceived self-efficacy does not cause the
reduction of fear (Tryon, 2005), it may function as an anchor for a child to engage in
exposure practice and a platform for a child to engage in additional and more difficult
exposure practice between sessions. This is notable, as Bandura (1997) maintained
that perceived self-efficacy influences one’s motivation to act or to persevere in the
face of difficulties.
There are multiple empirical investigations on child and adolescent perceived
self-efficacy reported in the literature. For instance, Tonge, King, Klimkeit, Melvin,
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Heyne, and Gordon (2005) developed and tested a measure of perceived self-efficacy
about coping with depressive symptoms in adolescents and found the measure’s
psychometric properties to be acceptable. Study results indicated higher pre-treatment
self-efficacy scores predicted better outcomes at three and six months post-treatment.
Similarly, Bandura and colleagues (1999) determined that perceived self-efficacy
influenced childhood depression and contributed to concurrent and subsequent
depression. Additionally, Warren and Salazar (2015) observed self-efficacy to be
associated with improvements in youth-reported symptoms of emotional distress and
behavioral dysfunction in routine mental health services. Self-efficacy has also been
found to be predictive of performance on cognitive tasks, such as academic
achievement and social adaptation (Magno & Lajom, 2008; Pastorelli, Caprara,
Barbaranelli, Rola, Rozsa, & Bandura, 2001). Multiple child and adolescent health
studies have also revealed high perceived self-efficacy to be predictive of proper
management of chronic conditions, such as weight loss behaviors (Walpole, Dettmer,
Morrongiello, McCrindle, & Hamilton, 2011), smoking behaviors (Ford, Oladopo,
Sterling, Diamond, Kelder, & McAlister, 2013), chronic pain (Bursch, Tsao,
Meldrum, & Zeltzer, 2006), chronic illness (Emerson et al., 2018) and exercise-related
behaviors (Pakarinen, Parisod, Smed, & Salantera, 2017). Considering the extant
literature on child perceived self-efficacy and child engagement during treatment, selfefficacy is an important factor to be explored in a study of engagement during
exposure.
The Current Study
The current study reports the development, psychometric evaluation, and field
testing of a measure of child/adolescent perceived self-efficacy to be used during
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exposure in CBT for children and adolescents with anxiety disorders. The purpose of
the measure is to facilitate the understanding of child/adolescent factors that contribute
to treatment engagement during exposure.
The study was conducted in two parts: 1. The development and psychometric
evaluation of the measure, including expert review and child response feedback, and 2.
Field testing of the measure to examine the relationship of child perceived selfefficacy to other variables during CBT for anxiety among children and adolescents.
See Study Flow Chart in Figure 1.
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Figure 1. Study Flow Chart
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The following hypotheses were tested: Hypothesis 1. Development of the SelfEfficacy during Exposure – Child version (SEE-C). Hypothesis 1a: Expert review will
appropriately tailor the SEE-C to the age and population of youth with anxiety
disorders on content validity and face validity. Hypothesis 1b: Participant review will
guide revisions to the SEE-C’s instructions, items, and item responses to assist with
validity of the measure. Hypothesis 1c: The internal consistency of the SEE-C will meet
or exceed α = .70.
Hypothesis 2. Examination of the relationship between the SEE-C and other key
variables. Hypothesis 2a: Self-efficacy, as measured by the SEE-C, will be related at pretreatment (and overtime) to anxiety symptoms, as measured by the Spence Children’s
Anxiety Scale (SCAS) and anxiety functional impairment, as measured by the Child
Sheehan Disability Scale for Anxiety (CSDS). Hypothesis 2b: Self-efficacy, as measured
by the SEE-C, will be related overtime to clinical improvement, as measured by the
Clinical Global Impression Scale (CGI). Hypothesis 2c: Self-efficacy, as measured by the
SEE-C, will be related at pretreatment (and overtime) to state motivation, as measured by
the Child Motivation Pediatric Motivation Scale (PMOT).
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CHAPTER 2

METHODOLOGY

Participants
Expert review. A sample of eight clinicians at least two-years post licensure with
expertise in the cognitive-behavioral treatment of childhood anxiety disorders was
identified and recruited for participation in the present study. Expert reviewers (88%
Female) endorsed employment throughout the United States from multiple clinical and
academic sites: Four were from universities, three were from academic medical centers,
and one was from both a medical center and private practice. Experts were at least two
years post licensure (M = 14.06 years; SD = 4.71), with more than 15 years of experience
in the cognitive-behavioral treatment of childhood anxiety disorders (M = 19.38 years,
SD = 4.24, range 15-25). Expert reviewers provided advice as to the face and content
validity of the SEE-C. Expert reviewer feedback was aggregated and findings integrated
(See Table 1 for Iterative Process).
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Table 1. Iterative Process of Feedback
Aggregation and Consensus
Quantitatively:
• Items will be summarized descriptively using frequencies, means and standard
deviations
Qualitatively:
• Item statements will be aggregated as to theme and consensus (i.e., frequency)
will be determined
• Frequency of consensus items will be analyzed as to outline considerations
Outlined considerations
Quantitatively:
• 100% participant agreement on a single item with a Mean = 7 or disagreement
with a Mean = 1 will be an item for editing
• Participant agreement on a single item with a Mean = 5 or 6 or disagreement with
a Mean = 2 or 3 will be an item considered for editing but additional reference to
the literature and advisor consultation will determine and justify scale adjustments
• Participant agreement on a single item with a Mean = 4 will not be considered for
editing
Qualitatively:
• Consensus statements on a single item endorsed by each reviewer (N = 8) will be
considered an item for editing
• Consensus statements on a single item endorsed by one to seven reviewers (N = 1
to 7) will be considered for editing but additional reference to the literature and
advisor consultation will determine and justify scale adjustments
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Field testing. A sample of 24 child-parent dyads was recruited from the Child
Anxiety Program (CAP) at the University of Rhode Island (URI). Children ranged in age
from 8 to 15 years (M = 9.9, SD = 1.93), with almost half the sample identifying as
female (46%) and identified as White, non-Hispanic. Children were in the 2nd to the 10th
grade, with more than half of the sample in the 3rd through the 6th grades. Additionally,
29% reported having a 504 plan in school. Parent participants identified as biological
parents, a mean age of 42.1 (SD = 5.67), predominantly female (83%), and identified as
White, non-Hispanic. The majority of children had biological parents living together
(92%) and an average annual income ranging from $100,000-$120,000. More than half
of parents reported a college degree or higher (92%). See Table 2 for an outline of
demographic information.
Retention rates. Twenty-four parent-child dyads consented to the field testing
portion of the study. Out of the 24 dyads, one child decided they no longer wanted to
complete study measures during the 1st session; however, the parent continued in the
study. At mid- and post-treatment, study retention rates remained the same, with 23 child
and 24 parent participants.
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Table 2. Sample Characteristics (N = 24 Child-Parent Dyads)
Child Gender n (%)
Female
11 (46)
Male
13 (54)
Child Age M (SD)
9.9 (1.93)
Child Race n (%)
White
24 (100)
Black/African American
0
Asian
0
American Indian/Alaskan Native
0
Native Hawaiian/Pacific Islander
0
Child Non-Hispanic n (%)
24 (100)
Child Grade n (%)
2nd Grade
1 (4)
3rd Grade
6 (25)
4th Grade
5 (21)
th
5 Grade
2 (8)
6th Grade
6 (25)
7th Grade
1 (4)
th
8 Grade
1 (4)
10th Grade
1 (4)
Child 504 Plan (Details unspecified) n (%)
7 (29)
Family Annual Income n (%)
Under $20,000
0
$20,001 - $40,000
1 (4)
$40,001 - $60,000
2 (8)
$60001 - $80,000
0
$80,001 - $100,000
1 (4)
$100,001 - $120,000
6 (26)
$120,001 and over
12 (50)
Not endorsed/missing
2 (8)
Child lives with n (%)
Bio mother and father
22 (92)
Bio mother
2 (8)
Parent in study n (%)
Female
20 (83)
Male
4 (17)
Parent Age M (SD)
42.1 (5.67)
Parent Relationship to child n (%)
Biological Parent
24 (100)
Parent Education Level n (%)
Some college
1 (4)
Associates Degree
1 (4)
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Bachelors (BA, BS)
Masters
PhD
MD
Parent Employment Status n (%)
Full-time
Part-time
Self-Employed
Not Employed
Prefer not to answer
Parent Martial Status n (%)
Married
Divorced
Did not answer
Parent Anxiety Disorder n (%)
Yes (past and/or current)
No

12 (50)
7 (30)
2 (8)
1 (4)
15 (62)
4 (17)
1 (4)
3 (13)
1 (4)
22 (92)
1 (4)
1 (4)
10 (42)
14 (58)
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All child participants met criteria for at least one anxiety disorder. Eighty-six
percent of the children met criteria for more than one disorder (anxiety or another type),
ranging from two to five (M = 2.58, SD = 1.06) comorbid disorders. Primary anxiety
diagnoses at pre-treatment included Generalized Anxiety Disorder (34%), Specific
Phobia (23%), Separation Anxiety Disorder (14%), and Social Anxiety Disorder (14%).
See Table 3 for a complete listing of pre-treatment diagnoses and comorbid conditions
counts.
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Table 3. Pre-Treatment Type and Frequency of Diagnoses
Diagnosis
Separation Anxiety Disorder
Generalized Anxiety Disorder
Social Anxiety Disorder
Specific Phobia
School Refusal
Misophonia
Obsessive Compulsive Disorder
Depressive Disorder
Attention Deficit Hyperactivity Disorder
Oppositional Defiant Disorder
Panic
None

Pre-Treatment
9
22
9
15
1
1
2
1
2
1
1
0

Frequency of Pre-Treatment Comorbid Diagnoses
Diagnoses Count
Pre-Treatment
0 Diagnoses
1 Diagnosis
2 Diagnoses
3 Diagnoses
4 Diagnoses
5 Diagnoses

0
3
8
9
3
1
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The first two participants of the 24 child-parent dyads enrolled were queried after
their completion of the SEE-C to glean information for response process validity. Two
child participants (M = 12 years; Male = 2) were queried about their experience and
understanding completing the SEE-C including the scale’s directions, questions, and
response items. Both child participants identified as White, non-Hispanic. Response
process feedback was aggregated and findings integrated.
Inclusion Criteria for the study were the following: 1) primary diagnosis of an
anxiety disorder using the Anxiety Disorder Interview Schedule – IV (ADIS-IV;
Silverman & Albano, 1996), adapted for DSM 5, 2) Child is between the ages of 8 and 17
years old and has a parent or legal guardian available to participate in treatment, and 3)
Child participant and parent are English speaking. Exclusion Criteria included a
documented child diagnosis of Psychosis, Autism, or Intellectual Disability and child use
of anti-depressant and/or anti-anxiety medications that has not been stable for more than
six weeks. Exclusion criteria were designed to be minimal and exclude only those
patients for whom CBT is not likely to be beneficial or may be risky.
Measures
Expert reviewer questionnaires were completed and edits to the developed
measure were made in prep for field testing. Field testing questionnaires were completed
at pre-treatment, mid-treatment (after completing 8 weeks of CBT and prior to initiation
of exposure practice), and post-treatment (session 16). All field testing questionnaires
were completed during scheduled intake or therapy sessions. See Appendix A for table of
administration time points.
Self-Efficacy During Exposure – Child (SEE-C). The SEE-C is a 9-item, child
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(ages 8 to 17 years old) self-report measure of perceived state self-efficacy during
exposure using a 5-point Likert scale from 1 (“Not sure at all”) to 5 (“Completely sure”).
Total scores range from 0 to 45, and higher numbers on total score indicate greater
perceived self-efficacy. Three subscales were defined in the construction of this measure:
‘success of handling distress during an exposure’ (items 1, 2, and 3), ‘success of
individual exposures themselves’ (items 4, 5, and 6), and ‘success of exposure treatment’
(items 7, 8, and 9). Items were selected following Bandura’s (2006) recommendations for
constructing scales of self-efficacy. Specifically, items were identified that had
reasonable face validity, were developmentally relevant to the target sample, and had
lower demand characteristics. Items were selected to incorporate a range of domains
relevant to children with anxiety and to yield a total perceived self-efficacy score and
subscales. See Appendix B for the original version of the measure (prior to edits via
expert reviewer and participant feedback) and Appendix C for the final edited version.
An identical parent version of the measure was developed, where parents reported
their perception of their child’s state self-efficacy during exposure. The parent version
was created to corroborate the child version, as a method to assist with the validity of the
child measure.
Expert Reviewer Questionnaires
Clinician Demographic Questionnaire (CDQ). The CDQ was completed by
expert clinicians (e.g., gender, education, institution). This information was used in
preliminary descriptive analyses to describe the expert clinician sample. See Appendix D.
Clinician Feedback Survey (CFS). The CFS was adapted from the Pediatric
Motivation Scale Service Provider Survey (Tatla, 2014) and used to obtain feedback from
expert clinicians upon review of the SEE-C. Questions on this survey include Likert scale
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and open-ended questions related to the measure’s face validity, clarity (i.e., conciseness,
grammar, readability, layout, reading level, and redundancy of questions) and clinical
utility (i.e., ease of administration, time to administer, and challenges in use). To
corroborate findings, information was reviewed qualitatively and quantitatively and then
aggregated to revise and refine the SEE-C. See Appendix D.
Semi-structured Administration Questionnaire (SSAQ). The SSAQ was
adapted from the Administration Questionnaire (Tatla, 2014). This questionnaire was
used to query child/adolescent participants about their experience completing the SEE-C.
Child/adolescent participants were asked about their understanding of the scale’s
directions, questions, and response items. They were asked to provide any comments they
have in regards to each. To corroborate findings, queried information was summarized
and aggregated to revise and refine the SEE-C. See Appendix D.
Field Testing Questionnaires
Caregiver Demographics. This demographics questionnaire was completed by
parents at baseline and includes questions regarding family composition, parent
information (e.g., age, gender, race, ethnicity, education, income, occupation), and child
information (e.g., age, gender, race, ethnicity, education). See Appendix D.
Anxiety Disorder Interview Schedule for Children for DSM-IV (ADIS-IV),
adapted for DSM 5 (American Psychiatric Association (APA), 2013). The ADIS-IV
(Silverman & Albano, 1996), a structured diagnostic interview for children (ages 7 – 17
years) is based on the Diagnostic Statistical Manual-IV (DMS-IV; American Psychiatric
Association (APA), 2000), was adapted to correspond to DSM 5 diagnoses. Parent and
children were interviewed separately using the ADIS, and reports were combined to form
consensus diagnoses. The ADIS-IV (adapted for DSM-5) was used to determine study
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inclusion criteria related to child/adolescent diagnoses. Graduate student clinicians
demonstrated a strong interrater reliability on the ADIS, Cohen’s kappa > or = .6) before
participating in the present study (ADIS; DiNardo et al., 1994).
Spence Children’s Anxiety Scale (SCAS). The SCAS (Spence, 1997; child and
parent versions) is a 38-item measure of a child’s anxiety. Scoring includes an overall
(total score) of anxiety that is made up of six subscales (separation anxiety, social phobia,
obsessive-compulsive disorder, physical injury fears, generalized anxiety,
panic/agoraphobia) each tapping a specific aspect of child anxiety utilizing a four-point
scale of how often things occur: 0 = never, 1 = sometimes, 2 = often, or 3 = always. The
greater the score, the more anxiety symptoms present. In this sample, both the child and
parent versions of the SCAS demonstrated good reliability (α = .884; α = .853,
respectively).
Child Sheehan Disability Scale for Anxiety (CSDS). The CSDS (Whiteside,
2009) is a 3-item measure assessing impairment in child functioning related to anxiety
and has excellent psychometric properties. Increased composite score indicates greater
impairment.
Clinical Global Impression (CGI). The CGI (Guy, 1976) is a 2-item, 7-point
scale measuring clinician-rated client severity (0 = Not assessed to 7 = Among the most
extremely ill patients) and improvement (0 = Not assessed to 7 = Very much worse)
during treatment. An increase in clinician ratings denotes worsening symptoms for both
scales.
Pediatric Motivation Scale (PMOT). The PMOT (Tatla, Jarus, Virji-Babul, &
Holsti, 2015) is a 19-item, child self-report measure that examines a child’s (8 to 19
years) perceived motivation during therapy. Items are rated on a scale from 0 (Not true at
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all true) to 5 (Definitely true). Average total score indicates child’s overall state
motivation with higher scores indicating greater state motivation. This measure
demonstrated good reliability in this sample (α = .815).
Procedure
Internal Review Board (IRB) approval was granted through the University of
Rhode Island.
Expert review. Expert reviewers were identified from the extant literature based
on their expertise on anxiety disorders in children and adolescents. A list of twenty-one
experts was identified and contacted to determine their interest in participating in the
study. Confirmation of their areas of expertise and relevant experience was solicited as
study inclusionary criteria. After informed consent was obtained, each expert reviewer
was asked to complete the Clinician Demographic Questionnaire and was provided a
summary of findings on the self-efficacy for exposure review of the literature to provide
current information justifying the measure development. Then, expert reviewers were
provided directions on the administration of the SEE-C and asked to complete the
Clinician Feedback Survey.
Field testing. Recruitment efforts focused on parents and children seeking
treatment at the University of Rhode Island (URI)’s Psychological Consultation Clinic’s
(PCC) Child Anxiety Program (CAP). In tandem with the CAP clinic procedures, a short
phone screen by the PCC coordinator was used to identify potentially eligible
participants. The research study was introduced to families at this time and interested
parents were provided a short description of the study and an opportunity to ask
questions. Consistent with the CAP clinic procedures, eligible families were invited to the
clinic for a two-hour visit during which an intake assessment occurred.
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Informed parent consent and child assent for the present study was conducted
during the intake following the usual treatment consenting procedures for CAP. Families
were reminded that study participation was voluntary and could be discontinued at any
point during their treatment and the termination of their participation would not affect
their treatment status.
Following informed consent/assent, pre-treatment assessments were administered
with the parent and child. Families not interested in participating in the study were not
penalized and were free to continue with treatment in CAP, provided they met with entry
requirements specific to the CAP program. Families who agreed to participate in the
present study were provided a complementary treatment manual (value ~$25) as
compensation for their participation. The consent, assessment, and treatment procedures
were video recorded (as consistent with CAP procedures) to ensure accuracy of
procedures, and videotapes were destroyed in alignment with APA, Health Insurance
Portability and Accountability Act (HIPAA), and PCC requirements.
Child participant reviewers. The first two participants of the 24 child-parent
dyads recruited were queried about their experience completing the SEE-C using the
SSAQ. Participants’ response processes was observed and recorded while they complete
the SEE-C pre-session. Research staff queried on items from the SEE-C that seemed
difficult to answer or appeared confusing to participants. Participants were also asked to
explain the rationale for their response selections to further evaluate participants’
understanding of the SEE-C items. In order to minimize the effects of social desirability,
a study research assistant administered the scale to the child, and the treating therapist
was not present. Information gleaned on the SSAQ was reviewed quantitatively and
qualitatively and then used to revise and refine the SEE-C.
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Treatment. The treatment provided was CBT with exposure per the 16-session
Coping Cat treatment protocol (Kendall & Hedtke, 2006) and involved coping skill
instruction and practice to reduce anxiety. Length of treatment sessions was 50 minutes.
At each session, child and parent participants completed paper and pencil measures about
child perceived self-efficacy and motivation. At mid- and post-treatment, participants
were again asked to complete the study measures.
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CHAPTER 3

RESULTS

Data Analyses
Preliminary statistical analyses. All statistical analyses were conducted using
IBM SPSS Statistics version 24 (IBM Corp., 2016). Data were cleaned (frequencies,
means, standard deviations and ranges were examined) and scored, and tests of
assumption and normality for skewness and kurtosis were completed. Overall, study
measures were deemed normally distributed (See Table 4). Descriptive statistics were
used to summarize the sample characteristics. Continuous variables were summarized
using means and standard deviations. Categorical variables were described with
frequencies and percentages. Pre-treatment report of child prescribed anxiety medication
(n = 2; Zoloft and Lorazepam) versus no medication were examined and showed no
significant differences on the SEE-C child version or anxiety symptom measures; as a
result, medication usage was not controlled for in the overall study analyses. Consistent
with an intent-to-treat approach, all participants were included in the data analyses.
Missing data. Utilizing maximum likelihood, expectation–maximization
algorithm (Allison, 2012), missing outcome data on randomly assigned participants were
replaced. A nonsignificant Little’s Missing Completely At Random (MCAR) test
suggests that the data were missing completely at random (Little, 1988). Maximum
likelihood imputation, using the expectation–maximization algorithm, was used to impute
the missing data (less than 5%) to improve statistical power with unbiased parameter
estimates (Enders, 2001; Scheffer, 2002). Missing data were imputed using the Missing
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Values Analysis (normal distribution; 25 iterations) within SPSS 24.0 (IBM, 2016).
Iterative feedback process. Expert review and child participant feedback assisted
in the established preliminary psychometrics of the SEE-C via evaluation of the
following forms of validity: 1) content validity, as demonstrated by a review of selfefficacy measures in the literature and expert review of the SEE-C; 2) face validity,
informed by expert review and field testing; and 3) response processing, determined by
child participant feedback during field testing. In addition, reliability was assessed after
field testing the SEE-C by examining internal consistency in the evaluation of
correlations between different items on the same test.
Expert reviewer and child participant feedback was integrated per outlined
considerations (including both quantitative and qualitative methods, which are outlined in
Table 1) and literature review. Item responses were summarized descriptively using
frequencies, means, and standard deviations and evaluated qualitatively through an
examination of themes and their frequency.
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Table 4. Pre-Treatment Measures
Pretreatment
Measure
SEE-C Child,
n=23
SEE-C
Parent, n=22
PMOT, n=22

Value
Range

Interpretation

Total
Score

Sample
Range

SD

Skew
-ness

Kurtosis

M

1 to 5

45

21-44

33.26

5.62

-.264

-.186

45

20-41

28.45

5.31

.317

-.100

95

66-95

81.18

8.91

.068

-.672

Spence Child,
n=24
Spence
Parent, n=24
Sheehan
Child School,
n=22
Sheehan
Child Social,
n=22
Sheehan
Child Family,
n=22
Sheehan
Parent
School, n=24
Sheehan
Parent Social,
n=24
Sheehan
Parent
Family, n=24
CGI Severity,
n=24
CGI
Improvement,
n=24

0 to 3

Higher: More
self-efficacy
Higher: More
self-efficacy
Higher: More
motivation
Higher: More
symptoms
Higher: More
symptoms
Higher:
Greater
impairment
Higher:
Greater
impairment
Higher:
Greater
impairment
Higher:
Greater
impairment
Higher:
Greater
impairment
Higher:
Greater
impairment
Higher: More
severe
Higher: Less
improvement

114

6-62

34.29

14.72

.173

-.686

114

12-54

31.29

12.02

.103

-.937

10

0-10

3.09

3.12

.863

-.290

10

0-9

3.05

2.84

.679

-.749

10

0-10

3.36

3.00

.765

-.473

10

0-10

5.13

2.68

-.175

-.612

10

0-9

5.46

2.75

-.827

-.096

10

0-9

4.67

3.07

-.127

-1.495

7

3-4

3.71

0.46

-.979

-1.145

7

0-4

3.50

1.35

2.422

4.210

1 to 5
0 to 5

0 to 3
0 to 10
0 to 10
0 to 10
0 to 10
0 to 10
0 to 10
0 to 7
0 to 7
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Expert Review
Tailoring the SEE-C per expert review. A sample of eight expert reviewers
were recruited to tailor the SEE-C to the age and population of the proposed sample with
emphasis on content and face validity. The CFS was used to obtain feedback on the
measure’s face validity, clarity, and potential clinical utility.
Responses on the CFS were reviewed, summarized, and aggregated for
incremental integration of the best representation of the construct of self-efficacy, ease
and clarity of reading the instructions for the scale, ease and clarity of reading the scale,
layout attractiveness, appropriateness of reading level appropriate for those as young as 8
years old, and ease of completion by children/adolescents. See Table 5 for summary of
CFS responses.
The CFS revealed that >50% of the expert reviewers thought the results of the
SEE-C would inform their intervention planning and treatment engagement during
exposure, the SEE-C items represented self-efficacy, and that youth with anxiety could
understand responses. More specifically, 50% “agreed” or “strongly agreed” that items
represented self-efficacy; 75% “agree” to “strongly agree” instructions were easy to
follow; 62% “agree” to “strongly agree” youth with anxiety could understand responses;
87.5% thought the layout of questions was attractive and appealing; 62.5% “somewhat
agree” and 25% “agree” reading level of SEE-C is appropriate for an 8-year old child;
100% “agree” to “strongly agree” a child with anxiety would not object to answering any
items on the SEE-C; 50% endorsed “<5 minutes” and the other 50% “5-10 minutes”
regarding how long they thought it would take to complete SEE-C; 100% thought “5-10
questions” was a reasonable number of questions to include on the SEE-C. Reviewers
indicated the measure results would inform intervention planning and treatment

26

engagement during exposure with 62.5% responding “yes,” 25% “possibly,” and 12.5%
left the question blank. Sixty-two percent believed this scale would be helpful to them as
a therapist. Thirty-seven percent believed that it might be useful. See Figure 2 for a
summary of expert reviewer feedback.
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Table 5. Expert Reviewer Feedback
Question prompt:
Q.) “In your opinion, would this scale be helpful to you as a therapist?”
Responses:
“Yes” = 5 (62.5%); “Maybe” = 3 (37.5%); “No” = 0 (0%)
If you answered “Yes” to Q., explain how this scale could be helpful to you:
Predict Better Treatment Outcomes:
“Good to prompt and guide clinical discussion about areas where there is less selfefficacy and may be able to predict outcome”
“Towards end of treatment, it would give therapist another source of ERP efficacy &
possibly predict treatment outcomes and maintenance of treatment gains”
Fill an Important Niche:
“I agree with you, the Child Self-Efficacy is not adequately assessed in CBT and this
would fill an important niche. Especially, if it is given as a repeated measure across
treatment to assess treatment-related changes in children's confidence. Nice job.”
Self-efficacy may be a Mechanism of Anxiety Reduction:
“If change in self-efficacy cognitions are a mechanism of anxiety reduction, this measure
may help test this hypothesis”
Assist with Engagement During Exposure:
“It might be helpful by providing a structured way to assess for the nuances associated
with the child's thoughts/beliefs about exposure tasks”
“It would help at beginning of treatment to assess a patient’s expectations about ERP and
allow the therapist to provide psychoeducation to enhance acceptability of treatment”
“Specifying child's belief in his/her efficacy can then become a target for intervention
(e.g., self-talk)”
“Yes, because you can assess expectations (in items 7-9) & attributions (in items 4-5)”
If you answered “Maybe,” explain how this scale may or may not be helpful to you:
“I am somewhat concerned that many of the items have to do more with outcome
expectancy and other constructs that are related to self-efficacy but are not really selfefficacy”
“I just wonder if children can rate their response to exposures in general. They may say
they can do some lower-level anxiety exposures but not believe they can do higher-level
exposure”
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Figure 2. Expert Reviewer Feedback
Thought the SEE-C Child would be helpful to them as a therapist:
62.5% = “yes” and 37.5% = “maybe”

If “Yes,” explain how this scale could be helpful to you:
• Predict better treatment outcomes
• Fill an important niche
• Self-efficacy may be a mechanism of anxiety reduction
• Assist with engagement during exposure
Thought the SEE-C Child would inform intervention planning and treatment
engagement during exposure:

Thought the SEE-C Child items represented self-efficacy:
12.5% = “strongly agree,” 37.5% =“agree,” and 25% = “somewhat agree”
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SEE-C response processing per child feedback. The SSAQ was used with two
child participants to elicit qualitative and quantitative feedback on the comprehension of
scale items and the understanding of response format. This information was used to
revise and refine the SEE-C. Both child participants described the developing measure as
needing more information regarding the definition and examples of exposure. Then, once
the SEE-C was revised and the additional information included, child participants
reported that the questionnaire was easy to understand and both required minimal
assistance to complete the questionnaire. They also indicated that they would willingly
complete the SEE-C, the questions were easy to answer, and they liked the formatting of
the responses. The SEE-C was edited via a formal iterative process with regard to agelevel readability, conciseness, and the need to add a definition and example of exposures.
Field Testing
Sample characteristics. A clinical sample of 24 treatment-seeking parent-child
dyads was enrolled into the study. One-way ANOVA’s were conducted on the number of
pre-treatment comorbid diagnoses (ranging from 1 to 5 diagnoses) by pre-, mid-, and
post-treatment on the child’s self-report of self-efficacy on the SEE-C. Due to the low
frequency of four (n = 3) and five (n = 1) diagnoses, these two values were collapsed to
one value (n = 4) for these analyses. Results indicated no difference in self-efficacy at
pre- and mid-treatment on the SEE-C child version; however, a significant difference on
child self-efficacy was seen at post-treatment by the number of pre-treatment comorbid
diagnoses (F(3,19) = 3.260, p=.044), where post hoc test revealed a difference
approaching significance (p = .056) between a comorbidity of two pre-treatment
diagnoses (n = 8) and four/five diagnoses (n = 4).See Table 6 for post-treatment
diagnoses frequencies and treatment counts.
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Table 6. Post-Treatment Type and Frequency of Diagnoses
Diagnosis
Separation Anxiety Disorder
Generalized Anxiety Disorder
Social Anxiety Disorder
Specific Phobia
School Refusal
Misophonia
Obsessive Compulsive Disorder
Depressive Disorder
Attention Deficit Hyperactivity Disorder
Oppositional Defiant Disorder
Panic
None

Post-Treatment
0
8
2
2
1
0
1
1
1
1
0
12

Frequency of Post-Treatment Comorbid Diagnoses
Diagnoses Count

Post-Treatment

0 Diagnoses
1 Diagnosis
2 Diagnoses
3 Diagnoses
4 Diagnoses
5 Diagnoses

12
10
1
0
1
0
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Examination of the SEE-C at Pre-treatment
Bivariate Pearson Correlation Coefficients were run between the pre-treatment
measures including the SEE-C, SCAS, CSDS composite scores and demographic
variables (child age and gender). Results showed that the SEE-C was significantly related
to parent report of child anxiety symptoms as measured by the SCAS (r = -.417, p =
.048). The parent and child report of anxiety symptoms were also significant and
positively correlated to each other (r = .715, p = .000). In addition, significant
relationships were found between the child report of anxiety symptoms and the child
report of functional impairment within the family (r = .502, p = .017), the parent report of
child functional impairment socially (r = .625, p = .001), and the parent report of child
functional impairment within the family (r = .688, p = .000). The child report of anxiety
symptoms was also significantly related to the clinician report of symptom severity on
the CGI (r =. 477, p = .018). See Table 6 for complete list of pre-treatment correlations.
Given the significant pre-treatment relationship between the SEE-C child version
and the SCAS parent version, as well as other pre-treatment measures, regression
analyses were conducted to examine whether the child symptoms of anxiety, functional
impairment, and motivation predicted to child self-efficacy. The first regression model
examined whether parent report and child self-report of pre-treatment anxiety symptoms
predicted child self-report of self-efficacy. Results approached significance, R2 = .232,
F(2, 22) = 3.019, p = .071, where only the parent report of child anxiety symptoms was
significantly predictive (β = -.646, t = -2.389, p = .027). Three additional regression
analyses examining (1) child self-report of state motivation, (2) child self-report and
parent report of child functioning, and (3) clinician report of child symptom severity and
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improvement as well as child age and gender as predictors of child self-report of selfefficacy were not significant.
Internal consistency of the SEE-C child version ranged from acceptable to
excellent at pre-, mid-, and post-treatment (Cronbach’s alphas of 793, .848, and .901,
respectively). Similarly, the SEE-C parent version demonstrated good to excellent
reliability, with Cronbach’s alphas of .874 at pre- treatment, .932 at mid- treatment, and
.901 at post-treatment.
Given the good pre-treatment internal consistency of the SEE-C child version as
one single dimension, an exploratory principle component analysis (PCA) using Varimax
rotation was performed on the 9-item scale to determine the underlying factor structure.
A three-factor solution, with loadings ranging from 0.5 to 0.9, emerged from the analysis.
Item one did not clearly load on a single factor but overlapped on two (Factor 1, ‘belief in
success of handling distress during an exposure,’ and Factor 3, ‘belief in success of
exposure treatment’). Items two, three, and four loaded on Factor 1 (‘belief in success of
handling distress during an exposure’); items five, six, and nine loaded on Factor 2
(‘belief in success of individual exposures themselves’); and items seven and eight loaded
on Factor 3 (‘belief in success of exposure treatment’). Cronbach alphas for each factor
showed promising results with acceptable to good internal consistency, as Factor 1 had an
α =. 748, Factor 2 had anα = 708, and Factor 3 had an α = .831 (item one was
eliminated from these analyses due to the overlap between two factors). While three
meaningful constructs are suggested, no clear determination of factor loadings can be
made, at this point, due to the small sample size.
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Examination of the SEE-C at Mid- and Post-Treatment
An exploratory examination at both mid- and post-treatment of the relationship
between parent and child report of child anxiety symptoms, functioning, and clinician
report of symptom severity and improvement were conducted (See Tables 7 & 8).
Specifically, at mid-treatment, clinician report of child symptom severity was negatively
correlated to child self-report of self-efficacy (r = -.603, p = .003). At post-treatment,
child self-report of self-efficacy was inversely related to child self-report of anxiety
symptoms (r = -.611, p = .004), parent report of child anxiety symptoms (r = -.545, p =
.016), parent report of child functioning within the family (r = -.605, p = .006), and
positively correlated to both parent report of child self-efficacy (r = .484, p = .023) and
clinician report of improved symptoms (r = .527, p = .012).
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Due to significant relationships at mid-treatment and at post-treatment between
the SEE-C and other constructs, hierarchical multiple regressions were performed to
assess whether certain variables predicted to lower child anxiety symptoms at midtreatment and at post-treatment. Significant results were seen when modeling posttreatment child self-report of self-efficacy on the SEE-C and PMOT (motivation) and
predicting to post-treatment child self-report of anxiety symptoms via the SCAS after
controlling for pre-treatment child self-report of anxiety symptoms, self-efficacy, and
motivation. Results demonstrated that there was a significant effect (F(5, 13) = 4.348,
p = .015, R2 = .626), where, after controlling for pre-treatment variables, at posttreatment higher child-report of self-efficacy predicted to lower anxiety symptoms via
child-report (β = -.574, p = .013). Individual predictors were examined and are
reported in Table 9.
Evaluation of the SEE-C Overtime
Repeated measures MANOVAs were conducted on all measures and groups of
measures with the same construct (i.e., child self-efficacy, child anxiety symptoms,
child motivation, and child functioning) across pre-, mid-, and post-treatment.
Significant differences were seen overtime on most constructs. Particularly, findings
showed that the SEE-C child and parent versions demonstrated significant, large
effects from pre-, to mid-, to post-treatment (F(2, 18) = 7.976, p = .000, ηp2 = .301).
Bonferroni post hoc tests showed that participants experienced a significant change on
the child version, p = .044, from pre-treatment to mid-treatment and on the parent
version with significant increases from pre- to post-treatment (p = .017), mid- to posttreatment (p = .010), and pre- to post-treatment (p = .000). See Figure 3. The child and
parent anxiety symptoms measures (See Figure 4) also showed large effects and
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significant differences overtime, F(2, 17) = 10.845, p = .000, ηp2 = .383. Post hoc tests
revealed that the parent report demonstrated significant decreases in anxiety symptoms
over time: pre- to post-treatment (p = .023), mid- to post-treatment (p = .000), and preto post-treatment (p = .000).
Additionally, child and parent functional impairment measures as well as the
clinician ratings measures also demonstrated significant change across time, with
medium to large effect sizes. For instance, parent and child report of child social
impairment (See Figure 5) was significant overtime with a medium effect size, F(1,
17) = 3.146, p = .020, ηp2 = .160. Post hoc tests showed significant mean difference
between pre- to post-treatment, where social function increased overtime (p = .012).
Similarly, with a medium effect size, parent and child report of child impairment (See
Figure 6) within the family was significant overtime (F(1, 17) = 3.190, p = .019, ηp2 =
.162), with post hoc differences seen from pre- to post-treatment (p = .008), showing
an increase in child functioning within the family. Finally, a large effect size and
significant difference overtime was seen on the clinician rating (See Figure 7) of child
symptom severity and improvement (F(2, 21) = 9.963, p = .000, ηp2 = .317). Clinician
report on child symptom severity demonstrated significant differences (decreases)
between pre- to post-treatment (p = .000) and mid- to post-treatment (p = .001), and on
child improvement (increased in improvement) between pre- to post-treatment (p =
.003) and mid- to post-treatment (p = .000). See Table 10 for a complete list of
measures, means, standard deviations, and statistical values.

39

40

41

42

43

44

45

46

CHAPTER 4

DISCUSSION

This study fills a gap in the literature with the development, preliminary
psychometric evaluation of reliability and validity, and field testing of a questionnaire of
child self-efficacy to be used during exposure in CBT for pediatric anxiety disorders. The
purpose of developing the SEE-C was to facilitate the understanding of child/adolescent
factors that contribute to treatment engagement during exposure. Overall, the SEE-C
child version was found to be helpful to therapists, particularly during treatment planning
and engagement during exposure. It demonstrated good face and content validity,
acceptable to excellent internal consistency/reliability from pre-treatment to posttreatment on the measure as a whole, and a promising three-factor structure that
demonstrated acceptable to good internal consistency per factor.
Much of the literature on child anxiety treatment focuses on treatment outcomes
of CBT with exposure but not on the effects of child engagement during exposure. Child
factors that may influence this engagement, as postulated in the theory of positive
psychological momentum, include perceived self-efficacy and motivation. As study
findings suggest, self-efficacy and motivation are relevant and important to child
engagement during exposure, as they predicted to reduced anxiety symptoms at posttreatment. Additionally, child self-efficacy was significantly related to child anxiety
symptoms, child symptom severity, and level of child functioning within the family at
pre-, mid- and post-treatment.
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Sample Comorbidity
This clinical sample of treatment-seeking parents and youth, while consistent with
previous research on many demographic characteristics, demonstrated at pre-treatment
that greater than half of the youth met criteria for multiple diagnoses of anxiety disorders
as well as other disorders. Specifically, 71% of the sample received at least two or three
concurrent diagnoses determined via a semi-structure assessment (ADIS-IV revised for
DMS-5 (APA, 2013)). Further, post-treatment outcomes indicated that 50% of children
ended treatment with no diagnoses and another 42% met criteria for only one diagnosis
(80% of which was a single anxiety disorder diagnosis). These statistics mirror diagnoses
rates in other studies focused on CBT for pediatric anxiety disorders (i.e., CartwrightHatton et al., 2006).
This study’s focus is novel in its examination of self-efficacy as a factor
postulated to contribute to engagement during exposure and assist in explaining ‘why’
children engage in exposure. When considering the comorbid diagnoses, it seems that the
compounded symptom presentations would dampen the treatment outcomes seen in this
study; however, they did not. Interestingly, among this small clinical sample, child selfefficacy did not differ according to comorbidity (presence/absence) at pre- and midtreatment. However, significant differences in post-treatment child self-efficacy were
found between those children who had two diagnoses versus those with four to five
diagnoses in that those with greater comorbidity showed less perceived self-efficacy than
those with fewer diagnoses at the end of treatment.
The SEE-C: Psychometric Evaluation
Expert reviewer and youth feedback indicated that the SEE-C child version
showed acceptable and appropriate face and content validity. The measure was found to
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be adequate in design and content for the age and population under study. The measure
also subjectively appeared to measure the construct it was supposed to measure. For
example, expert reviewers indicated an interest in the creation of the SEE-C as a tool to
address a child’s in-session beliefs about self-efficacy during exposure practice. Expert
reviews were also positive about the SEE-C’s ability to measure one of the child factors,
i.e., self-efficacy, that is likely to improve treatment engagement during exposure and
resultant treatment outcomes.
Because of the acceptable to excellent internal consistency for the measure as a
whole, exploratory PCA with Verimax rotation was utilized and suggested a three-factor
structure. These three factors appear relevant to the measure, and the results are
promising, as future confirmation of the factor structure (i.e., subscales) may better
explain the results of a child’s self-efficacy overtime, therefore providing greater
information as to a child’s engagement during exposure. For instance, in this pilot study,
the child-report of self-efficacy demonstrated a significant increase from pre- to midtreatment; however, it then slightly reduced from mid- to post-treatment (although still
significantly increased from pre-treatment). While these results are interesting, the reason
for the increase and slight decrease can only be inferred. Where as, if we were able to
utilize the measure’s subscales, we could better explain a child’s perceived self-efficacy
overtime via the more concise definition of each subscale, as each of the factors would
explain a unique component of the child’s self-efficacy.
In addition, there was significant positive association and medium effect size
between the SEE-C child version and the SEE-C parent version at post-treatment. While
is does not provide evidence of construct validity (the degree to which a measure
adequately evaluates the construct it claims to assess), since both measures are newly
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created, it does further assist in supporting the face and content validity. This is observed
as both the parent and the child responder appeared to understand and be able to report on
perceived child self-efficacy during exposure. While there is no simple metric to quantify
this measure’s construct validity (Westen & Rosenthal, 2003), particularly because this
appears to be the first to measure self-efficacy in CBT for pediatric anxiety, correlations
between the SEE-C child version and measures of child anxiety symptoms and
functioning demonstrate relationships in directions expected in a measure of selfefficacy. For example, there was a negative association and large effect size of reported
child anxiety symptoms with child self-reported self-efficacy as well as another negative
correlation and large effect size between child functioning and child self-reported selfefficacy.
Engagement During Exposure
In order for CBT with exposure to be effective, exposures must be completed, as
exposures are one of the main or “active” ingredients in CBT for pediatric anxiety
disorders (Hudson & Kendall, 2002). As such, a focus on the engagement during
exposure practice is necessary. Engagement is not always easy, as it involves multiple
components including a motivational commitment and behavioral involvement and a
child’s participation, therapist and child collaboration, and the child’s belief of selfefficacy to continue in the agreed-upon and identified intervention (King, et al., 2014).
Additionally, and as stated earlier, Positive Psychological Momentum (PPM) is the
“perception, attitude, belief, or state-of-mind an individual experiences, in which their
initial success leads to more successes” (Iso-Ahola & Blanchard, 1986). So, the hope is
that once a child feels self-efficacious in completing a task competently multiple times
(such as exposures), he/she will become confident in their abilities. As a result, a child’s
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in-session self-efficacy and motivation to experience and feel distress in the face of a
feared stimulus may be one of the important ingredients in the engagement in exposure
practice.
Perceived self-efficacy and motivation. Study findings indicate that child
perceived self-efficacy is negatively related to child anxiety symptoms over time (pre-,
mid-, and post-treatment), whereby when a child’s perceived self-efficacy is low, their
anxiety symptoms are high. Furthermore, as treatment progresses, a child’s self-efficacy
increases and their anxiety symptoms decrease. This is also true in the relationship
between child perceived self-efficacy and symptom severity as well as functional
impairment (social, school, and family domains). These findings provide evidence into
one, seemingly impactful, factor that contributes to a child’s engagement during
exposure.
This study’s goal was to define child factors that contribute to engagement in
exposure, including the perceived self-efficacy and motivation a child believes he/she has
and uses to incrementally approach a feared situation/event. However, by identifying
factors that influence engagement, we also need to consider that these factors under
investigation may be stimulated by the anxiety (the “challenge”) that maintains the
momentum to generate self-efficacy and motivation. Once a “challenge” is conquered,
another “cycle” of momentum needs to be generated to deal with the next challenge.
Depending on the child, it may take some time to build the stamina needed to wade
through potentially multiple challenges presented by anxiety. A focus on additional child
factors of engagement during exposure are outside the scope of this current study;
however, the consideration of these additional factors is necessary and leads us to the
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future directions of this research, as well as highlights the importance of and need to
consider parent and therapist factors that may exist.
Limitations
While this study has multiple strengths, it does not go without limitations. Expert
reviewers reviewed the measure only once rather than multiple times through an iterative
feedback process. While an iterative process would have provided more feedback
regarding the edited measure’s face validity, a consensus regarding the measure’s clinical
utility occurred with a singular review. This study was also limited by the child feedback
portion of the study, as there was a small sample size of child reviewers (N=2) and no
variation in gender and age. However, these were the first two recruited child participants
into the study and defined by the research proposal to be the child feedback participants.
Nonetheless, the child reviewers’ feedback was valuable and provided information on the
developing measure in a structured interview after the measure was administered, and the
children’s answers were queried in real-time. This feedback was thorough and
qualitatively as well as quantitatively assisted in shaping the measure. Additionally, the
homogeneity of the field testing sample makes the SEE-C non-generalizable to
populations who are dissimilar. There was no control group for comparison. Future
research should include a randomized control clinical trial. Study findings would be
stronger if psychiatric diagnoses were assessed at post-treatment and if follow-up
assessments were completed. In the present study, post-treatment diagnoses were
determined by each treating clinician without the use of a structured diagnostic
instrument.
In sum, the present study addresses a gap in the literature by developing a
measure that identifies a child’s self-reported, perceived ability (i.e., self-efficacy) to
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complete exposures during CBT for anxiety disorders. This research contributes to the
understanding of child engagement during exposure in CBT for anxiety disorders and,
thus, may help to improve treatment outcomes by calling attention to those factors
influential in a child’s ability to make the most of exposures during CBT treatment.
Necessary next steps are to further test and validate the developed measure. Once
determined valid and reliable, future research could examine whether a child’s perceived
in-session self-efficacy during exposure predicts to a child’s between-session selfefficacy during exposure, as well as whether self-efficacy predicts a child’s motivation to
do a greater amount and/or more difficult exposures during CBT for anxiety disorders
over time.
Future directions for research include the need for a randomized controlled
longitudinal study using the SEE-C, as well as an examination of other child factors
likely to influence child engagement during exposure and, ultimately, procure improved
treatment outcomes. In addition, a larger sample size would assist in greater measurement
testing and the confirmation of psychometric properties such as reliability of domain
factor structure, test-retest reliability, and criterion related validity. Similarly, parent and
clinician factors that influence engagement during exposure also need to be explored. For
instance, parent factors to be examined include parent accommodation, knowledge about
exposure and exposure practice, and parent perceived self-efficacy (or belief) about their
child’s ability to complete exposures. Clinician factors worthy of study include
clinicians’ beliefs about their client’s ability to complete exposure practice, knowledge of
and ability to employ motivation enhancement techniques, rapport building skills, and
skill and ability to individualize and create appropriate and effective exposures.
Additionally, motivation and growth mindset are two areas that are important when
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considering child factors that influence engagement during exposure that may, ultimately,
contribute to better treatment outcomes. For example, motivation is important for
ongoing behavior change during psychotherapy and has been documented to improve
efficacy in treatment of anxiety disorders, obsessive-compulsive disorders, depression,
and substance use (e.g., Cox, Blount, Bair, & Hosier, 2000; DiClemente, 1999;
Lombardi, Button, & Westra, 2014; Ponzini, Van Kirk, Schreck, Nota, Elias, 2019).
The area of growth mindset is equally important to consider as a child factor
influencing engagement during exposure. Growth mindset is based on the belief that
basic trait qualities are things you can cultivate and grow through your efforts because
they are malleable - not fixed (Dweck, 2008). Utilizing this mindset, one can conceivably
challenge themself to try something new and learn from it, just by sticking with it, even
when it is difficult (as in the case of exposure practice during the treatment for anxiety
disorders; Dweck, 2016). Research on growth mindset and anxiety has been
demonstrated and shows promising results (e.g., Schleider & Weisz, 2018). As such,
more research is needed to continue to explore this factor.
To conclude, CBT with exposure for childhood anxiety disorders is demonstrated
effective in reducing child anxiety over time; however, it is not 100% effective. As such,
research needs to identify the factors impacting child engagement during exposure to
assist in the creation of additional clinical tools and, ultimately, better treatment
outcomes.
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Appendix A. Outline of Assessments and Schedule of Administration

Assessment

Expert (E)
/Child (C)
/Parent (P)
/Therapist
(TH)

Pretreatment

10
mins

E

x

20
mins

E

x

1.5
hours

C/P

x

10
mins

P

x

10
mins

C/P

10
mins

Length

End of
Each
Treatment
Session

Week
8

Posttreatment

x

x

x

C/P

x

x

x

5 mins

C

x

x

x

5 mins

C/P

x

x

x

3 mins

TH

10
mins

C

Expert Reviewer:
Expert Demographics Sheet
Expert Survey (adapted
from the Pediatric
Motivation Scale Service
Provider Survey; Tatla,
2014)
Field Testing: ChildParent Dyads
Anxiety Disorder Interview
Schedule IV – Child Version
(ADIS-IV-C; Silverman &
Albano, 1996)
Parent Demographics
Sheet
Spence Children’s Anxiety
Scale (SCAS; Spence,
1997)
Sheehan Disability Scale
for Anxiety (SDSA;
Whiteside, 2009)
Pediatric Motivation Scale
(PMOT; Tatla, Jarus,
Virji-Babul, & Holsti,
2015)
Self-Efficacy During
Exposure – Child (SEE-C)
Clinical Global Impression
(CGI; Guy, 1976)
First two (2)
child/adolescent
participants:
Semi-structured
Administration
Questionnaire (SSAQ;
adapted from the
Administration
Questionnaire; Tatla, 2014)
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x

x
(after 1st
treatment
session
only)

Appendix B. Original version of the SEE-C Child
Self-Efficacy during Exposure – Child version (SEE-C)
Each question will ask you to tell how “sure you are” that you can do a certain thing
during your exposure, and to provide an answer that best matches your feeling.
Remember, an exposure is an agreed upon task or situation that allows you to practice
facing your fears.
Practice items: If you were asked to do each of these things, how sure are you that you
could:
a) Jump into a cold pool of water…
Not sure at all A tiny bit sure
Somewhat sure
0
1
2
b) Eat a dessert of your choice…
Not sure at all A tiny bit sure
Somewhat sure
0
1
2

Mostly Sure
3

Completely sure
4

Mostly Sure
3

Completely sure
4

How sure are you that you can do each of the following things during an exposure?
1. Stay in a scary or uncomfortable situation…
Not sure at all A tiny bit sure
Somewhat sure
Mostly Sure Completely sure
0
1
2
3
4
2. Sit with a scared or uncomfortable feeling/emotion…
Not sure at all A tiny bit sure
Somewhat sure
Mostly Sure
0
1
2
3

Completely sure
4

3. Sit with a scary or uncomfortable thought…
Not sure at all A tiny bit sure
Somewhat sure
0
1
2

Completely sure
4

Mostly Sure
3

How sure are you that each of the following things will happen during an exposure?
4. Your fear will go down, all on its own…
Not sure at all A tiny bit sure
Somewhat sure
Mostly Sure
0
1
2
3

Completely sure
4

5. You will be able to bring your fear down on your own…
Not sure at all A tiny bit sure
Somewhat sure
Mostly Sure
0
1
2
3

Completely sure
4

6. You will learn whether the thing you fear happens as you thought it would…
Not sure at all A tiny bit sure
Somewhat sure
Mostly Sure Completely sure
0
1
2
3
4
page 1 of 2
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How sure are you that each of the following things will happen in the future, after
you work hard on many exposures?
7. Exposures will help me be less afraid…
Not sure at all A tiny bit sure
Somewhat sure
Mostly Sure
0
1
2
3

Completely sure
4

8. Exposures will help keep my fears from getting in the way of the things I want to do…
Not sure at all A tiny bit sure
Somewhat sure
Mostly Sure Completely sure
0
1
2
3
4
9. Exposures will help me be stay less afraid after treatment is complete...
Not sure at all A tiny bit sure
Somewhat sure
Mostly Sure Completely sure
0
1
2
3
4
page 2 of 2
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Appendix C. Edited version of the SEE-C
SEE-C (Child version)

ID #: __________
Date: _____________

For Therapist Only: In the blank below, please list one situation/object that the
child has identified as scary or worrisome at a feelings thermometer rating of 4-6.
Read the text in italics aloud to the child. The child will then complete the
remaining sections on his/her own.
Today, I’m going to ask you some questions about things people do, and I’d like to know
how “sure you are” that you can do them.
For example: How sure are you that you could:
a) Jump into a cold pool of water…
Not sure at all

A tiny bit sure

Somewhat sure

Mostly Sure

Completely sure

Somewhat sure

Mostly Sure

Completely sure

b) Eat your favorite dessert…
Not sure at all

A tiny bit sure

OK, great! Now, I want to ask you how sure you are about doing some things during a
practice task. A practice task is an activity a person does to be less afraid of something –
like to be less afraid of a dog or bees or of the dark. When people are afraid of
something, they often try to stay away from it. Practice tasks slowly introduce a person to
what they are afraid so they get used to it.
For example, a practice task for a person who is afraid of spiders might be:
• thinking about (or imagines) a picture of a spider
OR
• looking at a picture of a spider in a book
OR
• looking at a spider on the wall
So remember, a practice task is an activity that slowly introduces a person to a
situation/object that they are afraid of.
You said earlier that you were afraid of ______________________________ (with a
feelings thermometer rating of 4-6). Imagine, for these next questions, that you are being
asked to do a practice task that involves this scary situation/object.
page 1 of 2
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Please circle ONE answer that matches your feeling. There are no right or wrong
answers to these questions. We just want to know how sure you feel today.

1. How sure are you that you can stay in a stressful/scary situation during the
practice task?
Not sure at all

A tiny bit sure

Somewhat sure

Mostly Sure

Completely sure

2. How sure are you that you can stay in a stressful/scary feeling (example:
feeling scared, stressed, worried) during the practice task?
Not sure at all

A tiny bit sure

Somewhat sure

Mostly Sure

Completely sure

3. How sure are you that you can stay in a stressful/scary thought (example:
thinking about something that is scary or stressful) during the practice task?
Not sure at all

A tiny bit sure

Somewhat sure

Mostly Sure

Completely sure

4. How sure are you that your fear will go down all by itself during the practice
task?
Not sure at all

A tiny bit sure

Somewhat sure

Mostly Sure

Completely sure

5. How sure are you that you will be able to lower your fear by yourself during
the practice task?
Not sure at all

A tiny bit sure

Somewhat sure

Mostly Sure

Completely sure

6. Over time, how sure are you that you will not be as scared of the
situation/object during the practice task?
Not sure at all

A tiny bit sure

Somewhat sure

Mostly Sure

Completely sure

7. How sure are you that practice tasks will help you be less afraid after you
have been doing practice tasks for a while?
Not sure at all

A tiny bit sure

Somewhat sure

Mostly Sure

Completely sure

8. How sure are you that practice tasks will help keep your fears from getting
in the way of the things you want to do after you have been practicing for a
while?
Not sure at all

A tiny bit sure

Somewhat sure

Mostly Sure

Completely sure

9. How sure are you that after you practice for a while with some help, practice
tasks will help you stay less afraid
Not sure at all

A tiny bit sure

Somewhat sure

page 2 of 2
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Mostly Sure

Completely sure

Appendix D. Adapted and Created Study Measures
Clinician Demographics Questionnaire
Today’s Date ______________
1. Please indicate the number of years you have been working as a licensed psychologist
in RI or MA with children and adolescents.
__________________________________________________________________
2. Please indicate the number of years you have been working specifically in the field of
anxiety and OCD with children and adolescents.
__________________________________________________________________
3. Please indicate the number of years you have been utilizing cognitive behavioral
therapy with exposure for anxiety and OCD treatment with children and adolescents.
__________________________________________________________________
4. What type of institution/agency/organization are you employed?
__________________________________________________________________
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Clinician Feedback Survey
You have been invited to participate in this study because you have expertise in the field
of anxiety disorders and obsessive-compulsive disorder (OCD). As a professional in the
area, you have knowledge about the acute discomfort children and adolescents with
anxiety disorders and OCD often experience during exposure practice in cognitive
behavioral therapy with exposure or exposure with response prevention. Your expertise
if valuable to us.
Based on your opinion, please answer to the best of your ability the following questions
about the Self-efficacy for Exposure – Child version (SEE-C). For each statement below,
please indicate whether you strongly agree, agree, somewhat agree, are neutral,
somewhat disagree, disagree, or strongly disagree.
1. The items on this scale appear to represent self-efficacy.
7. Strongly Agree
6. Agree
5. Somewhat Agree
4. Neutral
3. Somewhat Disagree
2. Disagree
1. Strongly Disagree
2. The instructions on the Self-efficacy for Exposure – Child version are easy to follow.
7. Strongly Agree
6. Agree
5. Somewhat Agree
4. Neutral
3. Somewhat Disagree
2. Disagree
1. Strongly Disagree
3. The questions on the Self-efficacy for Exposure – Child version are clear and easy to
follow.
7. Strongly Agree
6. Agree
5. Somewhat Agree
4. Neutral
3. Somewhat Disagree
2. Disagree
1. Strongly Disagree
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4. Children and adolescents with anxiety disorders and/or obsessive-compulsive disorder
will be able to understand and select an appropriate response (with minimal to moderate
assistance) using the response scale on a cue card.
7. Strongly Agree
6. Agree
5. Somewhat Agree
4. Neutral
3. Somewhat Disagree
2. Disagree
1. Strongly Disagree
5. The layout of the questions on the Self-efficacy for Exposure – Child version are
attractive.
7. Strongly Agree
6. Agree
5. Somewhat Agree
4. Neutral
3. Somewhat Disagree
2. Disagree
1. Strongly Disagree
6. The Self-efficacy for Exposure – Child version is at a reading level appropriate for an
8-year old child.
7. Strongly Agree
6. Agree
5. Somewhat Agree
4. Neutral
3. Somewhat Disagree
2. Disagree
1. Strongly Disagree
7. A child with anxiety disorders and/or obsessive-compulsive disorder would not object
to answering any items on the Self-efficacy for Exposure – Child version.
7. Strongly Agree
6. Agree
5. Somewhat Agree
4. Neutral
3. Somewhat Disagree
2. Disagree
1. Strongly Disagree
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8. In your opinion, has any major topic related to self-efficacy during exposure been
omitted?
_____________________________________________________________________
_____________________________________________________________________
9. How long do you think it will take a child to complete the Self-efficacy for Exposure –
Child version?
1. < 5 minutes
2. 5-10 minutes
3. 11-15 minutes
4. 16-20 minutes
5. 21-25 minutes
6. 26-30 minutes
7. > 30 minutes
10. During treatment, what is a reasonable length of time that you could spend
completing this scale with a child?
1. < 5 minutes
2. 5-10 minutes
3. 11-15 minutes
4. 16-20 minutes
5. 21-25 minutes
6. 26-30 minutes
7. > 30 minutes
11. Based on your experience with children and adolescents with anxiety disorders and/or
obsessive-compulsive disorder, what is a reasonable number of questions to include on
the Self-efficacy for Exposure – Child version?
1. < 5 questions
2. 5-10 questions
3. 11-15 questions
4. 16-20 questions
5. 21-25 questions
6. 26-30 questions
7. > 30 questions
12. In your opinion, would this scale be helpful to you as a therapist?
0. No
1. Yes
2. Maybe
13. If you answered yes to question 12, please explain how this scale could be helpful to
you.
_____________________________________________________________________
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_____________________________________________________________________
14. If you answered no to question 12, please explain why this scale would not be helpful
to you.
_____________________________________________________________________
_____________________________________________________________________
15. Are there any items on this scale that appear redundant or unnecessarily repeated?
_____________________________________________________________________
_____________________________________________________________________
16. Were any of the questions unclear or ambiguous? If so, would you say which one(s)
and why?
_____________________________________________________________________
_____________________________________________________________________
17. Are there any other obstacles or challenges you see in patients reporting their selfefficacy on the Self-efficacy for Exposure – Child version?
_____________________________________________________________________
_____________________________________________________________________
18. Would you add any other questions?
_____________________________________________________________________
_____________________________________________________________________
19. Do you think scale results can inform intervention planning or treatment engagement
during exposure?
_____________________________________________________________________
_____________________________________________________________________
20. Do you have any other comments you wish to share?
_____________________________________________________________________
_____________________________________________________________________
Thank you very much for your valuable feedback and suggestions!
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Semi-structured Administration Questionnaire
1. Was the child able to understand the instructions of the Self-Efficacy During Exposure
– Child version?
0 No
1 Yes
Comments:
_____________________________________________________________________
_____________________________________________________________________
2. Was the child able to understand the questions on the Self-Efficacy During Exposure –
Child version?
0 No
1 Yes
Comments:
_____________________________________________________________________
_____________________________________________________________________
3. Was the child able to understand the responses on the Self-Efficacy During Exposure –
Child version?
0 No
1 Yes
Comments:
_____________________________________________________________________
_____________________________________________________________________
4. How much assistance did the child require?
1. Minimal

2. Moderate

3. Maximum

Comment:
_____________________________________________________________________
_____________________________________________________________________
5. Did the child object to answering any of the questions?
0 No
1 Yes
Comments:
_____________________________________________________________________
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_____________________________________________________________________
How long did it take to complete the Self-Efficacy During Exposure – Child version?
_____________________________________________________________________
_____________________________________________________________________
Where any of the questions difficult or hard to answer?
0 No
1 Yes
If yes, which ones and why?
_____________________________________________________________________
_____________________________________________________________________
Would you add any other questions to the Self-Efficacy During Exposure – Child
version?
0 No
1 Yes
If yes, which ones and why?
_____________________________________________________________________
_____________________________________________________________________
Any other comments?
_____________________________________________________________________
_____________________________________________________________________
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Caregiver Demographics Sheet
Today’s Date: _________________
Participant Name: ____________________________
Caregiver’s name: ______________________________
Address: _____________________________________________________________
Child’s Age: __ __ (yrs) __ __ (mos)
Child’s Sex:

Male (0)

Child’s Ethnic Category:

Female (1)
Hispanic or Latino (1)

Not Hispanic or Latino (2)

Child’s Racial Category:
Caucasian (1)
African-American (2)
Asian/Pacific Islander (3)
Native American (4)
Multi-racial (5)
Other (6), specify:_____________________________
Biological Parents:
Mother: Age: _____
Check highest level of education obtained:
__ did not graduate from high school (1)
__ college graduate (4)
__ high school graduate (2)
__ advanced college degree (5)
__ some college (3)

Father:

Occupation:_______________________
Age: _____
Check highest level of education obtained:
__ did not graduate from high school (1)
__ college graduate (4)
__ high school graduate (2)
__ advanced college degree (5)
__ some college (3)
Occupation:_______________________

Child’s biological parents are:
__ married and living together (1)
__ unmarried and living together (2)
__ unmarried, not living together (3)
__ divorced (4)
__ separated (5)
The child lives with:

__
__
__
__

mother deceased (6)
father deceased (7)
both parents deceased (8)
unknown (9)

Biological mother and father (1)
Single Parent: Please note:
Mother (2)
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or

Father (3)

Mother and step-father (4)
Father and step-mother (5)
Equal time with separated/divorced parents (6)
Adoptive parents (6)
Other
(0):_____________________________________________
Approximate Household Yearly Income:
$20,000 or less (1)
$20,001 - $40,000 (2
$60,001 - $80,000 (4)
$80,001 - $100,000 (5)

$40,001 - $60,000 (3)
$100,000+ (6)

Child’s siblings (list ages):
age

age

Full brothers:
Full sisters:
Half-brothers:
Half sisters:
Step brothers
Step sisters
Current School:
(4)
Other (5)

Public (1)

Private (2)

Home Studies (3)

Not in School

Grade:________________
Has child ever attended resource, remedial, or special classes in the past?
Yes (1)

No (0)

If yes, describe:_______________________________________________________
Has child ever repeated a grade?
___________________
Current School Performance:
Above Average (4)

No (0)
Failing (1)

Yes (1) If yes, describe: Below Average (2)

Average (3)

Psychiatric History:
Has your child ever been hospitalized because of a behavioral, emotional, or psychiatric
problem?
No (0)
Yes (1) If yes, Child’s age: _____
Reason:_________________________________________
Medical History:
Has your child suffered from any of the following medical problems?
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__ head injuries (concussions, loss of consciousness) __ allergic reactions to
medications
__ seizures
__ other allergies
__ recurrent headaches
__ hospitalization for medical
illness
__ bone fractures
__ hearing impairment
__ asthma
__ surgery
__ other medical problems (describe)
If yes to any of the above, please provide details:

Medication History:
Please provide information about all medications that your child is currently taking:
Date started
(mo/yr)

Name of medication

Current Dose

Please provide information about medications that your child has taken for psychiatric
problems in the past:
Past Medications
Date started
Date stopped
Final Dose
(mo/yr)
(mo/yr)

Have any other family members had psychiatric / emotional problems?
Yes
If yes, please list relationship to child and problem experienced below:
Relative
OCD
Other

Tics/
Tourette’s

Mother –
biological

___________

Father biological

___________

Sister: Age
____

___________

Sister: Age
____

___________

Brother: Age
____

___________

Brother: Age
____

___________

Anxiety

Depression

Pat.
Grandmother
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Drugs/ Schizophrenia
Alcohol

No

___________
Pat.
Grandfather

___________

Mat.
Grandmother

___________

Mat.
Grandfather
Other Relative:
____________

___________
___________
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